Yeji

$KROS

Keros Therapeutics, Inc.

Runway:20+ yrs
NasdaqMarket cap: —CIK 0001664710

Upcoming catalysts

0 surfaced

No catalysts surfaced for KROS yet.

Drug pipeline

KER-047
Iron Deficiency Anemia
Dose A KER-012
Pulmonary Arterial Hypertension

Recent & active trials

NCTDrugPhaseStatusPrimary completion
NCT05927012KER-047Phase 2Withdrawn2025-08-29
NCT05975905Dose A KER-012Phase 2Completed2025-03-05